Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation
- PMID: 5034507
Item in Clipboard
Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation
Res Commun Chem Pathol Pharmacol.
1972 May.
No abstract available
Similar articles
-
Plasma kinetics of diphenylhydantoin in dogs and cats.Am J Vet Res. 1973 Jul;34(7):947-50. Am J Vet Res. 1973. PMID: 4720682 No abstract available.
-
Inhibition of diphenylhydantoin elimination by its major metabolite.Res Commun Chem Pathol Pharmacol. 1972 Sep;4(2):297-306. Res Commun Chem Pathol Pharmacol. 1972. PMID: 5074529 No abstract available.
-
Time for phenytoin concentration to peak: consequences of first-order and zero-order absorption.Ther Drug Monit. 1989 Sep;11(5):540-2. Ther Drug Monit. 1989. PMID: 2815228
-
[A simulation study on the characteristics in a steady-state for Michaelis-Menten elimination kinetics].Zhongguo Yao Li Xue Bao. 1986 Nov;7(6):483-8. Zhongguo Yao Li Xue Bao. 1986. PMID: 2955636 Chinese. No abstract available.
-
[5,5-Diphenylhydantoin (hydantoinal Polfa)].Neurol Neurochir Pol. 1973 Jan-Feb;7(1):79-84. Neurol Neurochir Pol. 1973. PMID: 4570505 Review. Polish. No abstract available.
Cited by
-
Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients.Br J Clin Pharmacol. 1974 Apr;1(2):155-61. doi: 10.1111/j.1365-2125.1974.tb00225.x. Br J Clin Pharmacol. 1974. PMID: 22454903 Free PMC article.
-
Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.Br J Cancer. 1979 Apr;39(4):441-4. doi: 10.1038/bjc.1979.78. Br J Cancer. 1979. PMID: 444399 Free PMC article.
-
Plasma level monitoring of anticonvulsants.Clin Pharmacokinet. 1976;1(1):52-66. doi: 10.2165/00003088-197601010-00005. Clin Pharmacokinet. 1976. PMID: 797492 Review.
-
Dose-dependent pharmacokinetics and cancer chemotherapy.Cancer Chemother Pharmacol. 1981;6(1):1-9. doi: 10.1007/BF00253003. Cancer Chemother Pharmacol. 1981. PMID: 7023712 Review.
-
Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling.Drugs R D. 2020 Dec;20(4):343-358. doi: 10.1007/s40268-020-00323-2. Epub 2020 Oct 7. Drugs R D. 2020. PMID: 33026608 Free PMC article.